Article Details
Retrieved on: 2022-03-25 20:20:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On March 25, 2022 , Vir Biotechnology, Inc. (the "Company") issued a press release announcing that the U.S. Food and Drug Administration ("FDA") ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here